Health Library
February 11, 2026
Question on this topic? Get an instant answer from August.
Idan an rubuta maka Zepbound kuma inshorar ka ta Aetna ce, tambayar farko da zaka yi ita ce game da kari. Tambaya ce mai kyau kuma mai mahimmanci. Waɗannan magunguna na iya cin kuɗi sama da $1,000 a wata ba tare da taimako ba, don haka sanin inda kake ya bambanta sosai.
Ga taƙaitaccen amsa: yawancin tsare-tsaren kasuwancin Aetna na yau da kullun sun daina rufe Zepbound don sarrafa nauyi tun daga ranar 1 ga Yuli, 2025. Amma hakan ba yana nufin duk wata kofa ta rufe ba ce. Wasu tsare-tsaren Aetna har yanzu suna rufe shi, ana iya buƙatar keɓancewa, kuma akwai zaɓuɓɓukan ajiyar kuɗi waɗanda zasu iya rage tsada sosai. Bari mu yi nazarin komai.
Har zuwa tsakiyar 2025, yawancin tsare-tsaren Aetna sun rufe Zepbound don sarrafa nauyi na tsawon lokaci. Hakan ya canza lokacin da CVS Caremark, wanda ke gudanar da fa'idodin kantin magani na Aetna, ya cire Zepbound daga jerin abubuwan da suka fi so. Formulary wata lissafa ce ta magunguna da inshorar ku ke yarda ta taimaka wajen biya.
CVS Caremark ya cimma yarjejeniya mafi kyau tare da mai yin Wegovy, wani magani na GLP-1 mai gasa, kuma ya mai da Wegovy mafi fifiko maimakon. Wannan canjin ya shafi duka Aetna Standard Plan da Advanced Control Plan formularies.
Don haka idan kuna kan ɗayan waɗannan tsare-tsaren na yau da kullun kuma kuka yi ƙoƙarin cike takardar neman Zepbound yau, a bayyane yake za a ce "ba a rufe shi ba". Abubuwan da aka jera sun haɗa da Wegovy, Saxenda, Qsymia, da orlistat.
Ana sa ran wannan keɓancewa za ta ci gaba har zuwa 2026 ga yawancin tsare-tsaren kasuwancin na yau da kullun.
Ee, wasu suna yi. Karin yana dogara ne akan irin tsarin Aetna da kuke da shi. Ba duk tsare-tsaren suna bin iri ɗaya ba.
Tsare-tsaren ma'aikata masu daukar nauyin kansu. Yawancin manyan ma'aikata suna gudanar da fa'idodin kiwon lafiyarsu ta hanyar Aetna amma suna yanke shawara mai zaman kanta game da magungunan da za su rufe. Idan ma'aikacin ku yana da tsarin daukar nauyin kansa, zasu iya zaɓar su ci gaba da Zepbound akan formulary koda kuwa tsare-tsaren Aetna na yau da kullun sun cire shi. Yana da daraja tambayar sashen HR ɗin ku ko tsarin kamfanin ku har yanzu yana tattara magungunan GLP-1 don sarrafa nauyi.
Tsare-tsaren da ke rufe Zepbound don ciwon barci mai tsanani (OSA). Zepbound ya sami amincewar FDA don matsakaici-zuwa-mai tsanani ciwon barci na obstructive a ƙarshen 2024. Wasu tsare-tsaren Aetna na iya ci gaba da bayar da kari lokacin da aka rubuta takardar musamman don OSA maimakon rage kiba. Duk da haka, har ma wannan hanyar ta zama abin dogaro, kamar yadda wasu tsare-tsaren suka cire Zepbound ga duka waɗannan alamomi.
Tsare-tsaren Aetna Medicare Advantage. Dokokin Medicare na yanzu gaba ɗaya ba sa rufe magungunan rage kiba. Duk da haka, Medicare na iya rufe Zepbound idan an rubuta shi don ciwon barci mai tsanani. Sabon shirin gwaji na tarayya mai suna BALANCE, an sanar a watan Disamba 2025, na iya faɗaɗa samun damar Medicare da Medicaid GLP-1 tun daga tsakiyar 2026. Sashen D na iya shiga ta hanyar Janairu 2027.
Ga tsare-tsaren Aetna waɗanda har yanzu suke rufe Zepbound, ana buƙatar izinin farko kusan koyaushe. Wannan yana nufin likitan ku yana buƙatar aika takardu zuwa Aetna don tabbatar da cewa magani yana da mahimmanci a likitance kafin kantin magani ya cika shi.
Ga abin da Aetna gaba ɗaya ke kallo yayin aiwatar da izinin farko:
Shawarwarin izinin farko gaba ɗaya suna dawowa cikin kwanaki ɗaya zuwa biyu. Idan an amince, har yanzu kuna da alhakin biyan kuɗin tsarin ku ko kuma kuɗin inshora bayan kun kai ga karatun ku.
Kusan kashi 50% na marasa lafiya suna buƙatar wani nau'in izinin farko, kuma kusan kashi ɗaya cikin huɗu ana tambayarsu su gwada wani magani daban a farko.
Ƙaryatawa ba lallai ba ne ta zama ƙarshen hanya. Kuna da haƙƙin doka don daukaka kara, kuma damar ba ta fi kyau kamar yadda kuke tsammani ba.
Bincike ya nuna cewa fiye da 80% na ƙaryatawar izinin farko da aka daukaka ana juyawa idan daukaka ta ta tattara takardu mai ƙarfi. Duk da haka, ƙasa da 10% na marasa lafiya suna damuwa don daukaka kara. Wannan rata tana wakiltar mutane da yawa waɗanda zasu iya samun kari amma sun daina da wuri.
Ga yadda tsarin daukaka kara ke tafiya gaba ɗaya:
Tsarin izinin farko na Aetna da fom ɗin buƙatar keɓancewa na iya aiko su ta likitan ku ta hanyar fax ko tsarin lantarki. An buƙaci kamfanonin inshora su amsa bukatun gaggawa cikin sa'o'i 72 a ƙarƙashin dokar tarayya.
Fahimtar yanayin tsada na iya taimaka muku shirya, komai inda karin ku yake.
Tare da kari na Aetna da katin ajiyar kuɗi. Idan tsarin ku ya rufe Zepbound, Katin Ajiya na Zepbound daga Eli Lilly na iya rage tsadar kuɗin ku har zuwa $25 a wata. Katin ajiyar kuɗi na 2026 yana rufe har zuwa $100 kowace wata, tare da iyakar shekara-shekara na $1,300. Wannan katin kyauta ne don kunnawa kuma yana samuwa ga duk wanda ke da inshorar kasuwanci.
Tare da Aetna amma babu kari na Zepbound. Idan kuna da inshorar Aetna wanda ba ya rufe Zepbound, katin ajiyar kuɗi har yanzu yana taimakawa. A wannan yanayin, kuna iya cancanci biya har zuwa $499 a wata don kwalban allura guda ɗaya. Katin yana rufe har zuwa $620 a kowane wata a cikin tanadi, tare da iyakar shekara-shekara na $8,060.
Babu inshora. Farashin Zepbound yana kusan $1,086 a wata. Ba tare da inshora ba, mafi kyawun zaɓin biyan kuɗi shine LillyDirect a halin yanzu, wanda ke bayar da kwalban Zepbound guda ɗaya daga $299 zuwa $449 a wata dangane da adadin.
Mutanen da ke da inshorar gwamnati (Medicare, Medicaid, TRICARE, ko VA) ba su cancanci shirin katin ajiyar kuɗi ba.
Idan Zepbound ba shi da yawa ga tsarin ku, Aetna tana rufe wasu magungunan sarrafa nauyi na madadin:
Kowannensu yana da buƙatunsa na izinin farko da tsarin tsadar kuɗi. Likitan ku na iya taimaka muku sanin wane zaɓi ya fi dacewa dangane da tarihin lafiyar ku da manufofinku.
Tun da kari ya bambanta sosai daga tsari zuwa tsari, duba fa'idodin ku wani muhimmin mataki ne. Ga wasu hanyoyi don yin hakan:
Shiga cikin portal ɗin membobin Aetna ku. Koma zuwa sashen kantin magani ko magungunan likita kuma yi amfani da kayan aikin duba magunguna don neman Zepbound. Zaɓi shekarar tsarin ku na yanzu kuma zai nuna ko an rufe maganin, a ƙarƙashin wane matsayi ya ke, kuma ko ana buƙatar izinin farko.
Duba Aetna kai tsaye. Shirya kat ɗin inshora da lambar tsarin ku. Tambayi mai ba da shawara musamman ko Zepbound yana kan formulary tsarin ku da kuma menene ƙa'idodin izinin farko.
Tambayi sashen HR na kamfanin ku. Idan kuna da tsarin daukar nauyin kanku, HR na iya bayyana ko kamfanin ku ya zaɓi haɗa magungunan sarrafa nauyi a cikin fakitin fa'idodi.
Shin Aetna na rufe Zepbound? Ga yawancin tsare-tsaren kasuwancin na yau da kullun, amsar a halin yanzu ba haka ba ce don sarrafa nauyi. Hakan ya canza a watan Yulin 2025 lokacin da CVS Caremark ya koma Wegovy a matsayin zaɓi na GLP-1 da aka fi so. Koyaya, tsare-tsaren ma'aikata masu daukar nauyin kansu, takamaiman takardun likita na OSA, da kuma nasarar keɓancewar formulary na iya buɗe ƙofar kari.
Idan an ƙaryata ku, daukaka kara tare da takardu mai ƙarfi na likita yana da daraja. Kuma idan kari ba shi da yawa ta hanyar tsarin ku, Katin Ajiya na Zepbound da LillyDirect suna ba da hanyoyi masu ma'ana don rage tsada.
Mafi mahimmanci shine kada ku yi tunanin cewa ƙaryatawa na nufin baku da zaɓuɓɓuka. Yi magana da likitan ku, duba cikakkun bayanai na tsarin ku, kuma bincika kowace hanya da ake samu. Samun damar kulawa yana da mahimmanci, kuma akwai hanyoyi masu yawa zuwa gare shi fiye da yadda yawancin mutane ke fahimta.
Bayanin Bayani: Wannan abun ciki don dalilai na bayanai ne kawai kuma baya maye gurbin shawarar likita ko inshora ta ƙwararru. Cikakkun bayanai na kari suna canzawa akai-akai. Koyaushe tabbatar da fa'idodin ku kai tsaye tare da Aetna kuma ku nemi likitan da ya dace don shawarwarin jiyya.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.